j&j featured image
News Pharmaceutical & Biotech Stories

Johnson & Johnson Files for Vaccine Emergency Use in Philippines

US drugmaker, Johnson & Johnson has applied for emergency use of its single-dose COVID-19 vaccine in the Philippines.

According to FDA Director-General Eric Domingo, J&J applied for emergency use authorization of the vaccine in the country on Wednesday, March 31.

Once authorized by the country’s FDA, Johnson & Johnson will be the fifth vaccine maker to get emergency use approval in the Philippines, following Pfizer-BioNTech, AstraZeneca, Sinovac, and Gamaleya Research Institute.

ASEAN HR TECH VENTURE SUMMIT 2018
REGISTER NOW 33% DISCOUNT
SUMMIT PASS